| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |